{"transactions":[{"id":4626158,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T20:29:33.000Z","date":"2026-09-23","kind":"sale","planned":false,"acquired":false,"shares":4528,"price":1.61,"value":7290.08,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.60 to $1.77 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001231919-26-001224","document":"form4-09242026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926001224/form4-09242026_080923.xml","form_type":"4"}},{"id":4626157,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T20:29:33.000Z","date":"2026-09-23","kind":"sale","planned":false,"acquired":false,"shares":114851,"price":1.61,"value":184910.11,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.60 to $1.77 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001231919-26-001224","document":"form4-09242026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926001224/form4-09242026_080923.xml","form_type":"4"}},{"id":4626156,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T20:29:33.000Z","date":"2026-09-22","kind":"sale","planned":false,"acquired":false,"shares":1088,"price":1.65,"value":1795.2,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":4528,"source":{"system":"sec-edgar","filing":"0001231919-26-001224","document":"form4-09242026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926001224/form4-09242026_080923.xml","form_type":"4"}},{"id":4626155,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T20:29:33.000Z","date":"2026-09-22","kind":"sale","planned":false,"acquired":false,"shares":27612,"price":1.65,"value":45559.8,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":114851,"source":{"system":"sec-edgar","filing":"0001231919-26-001224","document":"form4-09242026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926001224/form4-09242026_080923.xml","form_type":"4"}},{"id":4624123,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-18T22:37:58.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1285,"price":1.91,"value":2454.35,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $2.11 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":5616,"source":{"system":"sec-edgar","filing":"0001231919-26-001197","document":"form4-09182026_100949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926001197/form4-09182026_100949.xml","form_type":"4"}},{"id":4624122,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-18T22:37:58.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":32607,"price":1.91,"value":62279.37,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $2.11 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":142463,"source":{"system":"sec-edgar","filing":"0001231919-26-001197","document":"form4-09182026_100949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926001197/form4-09182026_100949.xml","form_type":"4"}},{"id":680029,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":6495,"price":0.32,"value":2078.4,"ownership":{"direct":false,"nature":"By 5AM Ventures VII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are directly held by 5AM Ventures VII, L.P. (\"Ventures VII\"). 5AM Partners VII, LLC (\"Partners VII\") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":7850155,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680028,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":46,"price":0.32,"value":14.72,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":55208,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680027,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":1159,"price":0.32,"value":370.88,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1400560,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680026,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":57476,"price":0.35,"value":20116.6,"ownership":{"direct":false,"nature":"By 5AM Ventures VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.33 to $0.36 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are directly held by 5AM Ventures VII, L.P. (\"Ventures VII\"). 5AM Partners VII, LLC (\"Partners VII\") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":7856650,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680025,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":409,"price":0.35,"value":143.15,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.33 to $0.36 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":55254,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680024,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":10255,"price":0.35,"value":3589.25,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.33 to $0.36 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1401719,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680023,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":253080,"price":0.38,"value":96170.4,"ownership":{"direct":false,"nature":"By 5AM Ventures VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.35 to $0.41 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are directly held by 5AM Ventures VII, L.P. (\"Ventures VII\"). 5AM Partners VII, LLC (\"Partners VII\") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":7914126,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680022,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":1830,"price":0.38,"value":695.4,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.35 to $0.41 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":55663,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":680021,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:57:08.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":45090,"price":0.38,"value":17134.2,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.35 to $0.41 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1411974,"source":{"system":"sec-edgar","filing":"0001231919-26-000959","document":"form4-08202026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000123191926000959/form4-08202026_090856.xml","form_type":"4"}},{"id":691893,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-10T23:52:46.000Z","date":"2026-08-07","kind":"sale","planned":false,"acquired":false,"shares":52317,"price":6.85,"value":358371.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.80 to $7.01 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2783781,"source":{"system":"sec-edgar","filing":"0001231919-26-000854","document":"form4-08102026_110837.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000123191926000854/form4-08102026_110837.xml","form_type":"4"}},{"id":691892,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-10T23:52:46.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":10494,"price":7,"value":73458.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.90 to $7.11 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2836098,"source":{"system":"sec-edgar","filing":"0001231919-26-000854","document":"form4-08102026_110837.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000123191926000854/form4-08102026_110837.xml","form_type":"4"}},{"id":698835,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T21:32:54.000Z","date":"2026-07-31","kind":"sale","planned":false,"acquired":false,"shares":1718,"price":6.85,"value":11768.3,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2846592,"source":{"system":"sec-edgar","filing":"0001231919-26-000822","document":"form4-08032026_090845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000123191926000822/form4-08032026_090845.xml","form_type":"4"}},{"id":698834,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T21:32:54.000Z","date":"2026-07-30","kind":"sale","planned":false,"acquired":false,"shares":114756,"price":6.93,"value":795259.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.95 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2848310,"source":{"system":"sec-edgar","filing":"0001231919-26-000822","document":"form4-08032026_090845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000123191926000822/form4-08032026_090845.xml","form_type":"4"}},{"id":995783,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:34:52.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":8.8,"value":1760000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.023 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2963066,"source":{"system":"sec-edgar","filing":"0001231919-25-000522","document":"form4-11182025_091144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000123191925000522/form4-11182025_091144.xml","form_type":"4"}},{"id":1058371,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-22T23:05:36.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":6470,"price":3.42,"value":22127.4,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.30 to $3.59 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":57493,"source":{"system":"sec-edgar","filing":"0001415889-25-022806","document":"form4-08222025_110831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588925022806/form4-08222025_110831.xml","form_type":"4"}},{"id":1058370,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-22T23:05:36.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":163979,"price":3.42,"value":560808.18,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.30 to $3.59 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1457064,"source":{"system":"sec-edgar","filing":"0001415889-25-022806","document":"form4-08222025_110831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588925022806/form4-08222025_110831.xml","form_type":"4"}},{"id":1058369,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-22T23:05:36.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":2314,"price":3.57,"value":8260.98,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.69 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":63963,"source":{"system":"sec-edgar","filing":"0001415889-25-022806","document":"form4-08222025_110831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588925022806/form4-08222025_110831.xml","form_type":"4"}},{"id":1058368,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-22T23:05:36.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":58642,"price":3.57,"value":209351.94,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.69 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1621043,"source":{"system":"sec-edgar","filing":"0001415889-25-022806","document":"form4-08222025_110831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588925022806/form4-08222025_110831.xml","form_type":"4"}},{"id":1088592,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-11T21:25:21.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":6935,"price":7.502,"value":52026.37,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1093313,"source":{"system":"sec-edgar","filing":"0001415889-25-019677","document":"form4-07112025_090716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925019677/form4-07112025_090716.xml","form_type":"4"}},{"id":1088591,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-11T21:25:21.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":20065,"price":7.502,"value":150527.63,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":3163066,"source":{"system":"sec-edgar","filing":"0001415889-25-019677","document":"form4-07112025_090716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925019677/form4-07112025_090716.xml","form_type":"4"}},{"id":1097868,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T00:32:14.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":6422,"price":7.1226,"value":45741.3372,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1100248,"source":{"system":"sec-edgar","filing":"0001415889-25-018822","document":"form4-07022025_120710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925018822/form4-07022025_120710.xml","form_type":"4"}},{"id":1097867,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T00:32:14.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":18578,"price":7.1226,"value":132323.6628,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":3183131,"source":{"system":"sec-edgar","filing":"0001415889-25-018822","document":"form4-07022025_120710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925018822/form4-07022025_120710.xml","form_type":"4"}},{"id":1097866,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T00:32:14.000Z","date":"2025-06-30","kind":"sale","planned":false,"acquired":false,"shares":6422,"price":6.8127,"value":43751.1594,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1106670,"source":{"system":"sec-edgar","filing":"0001415889-25-018822","document":"form4-07022025_120710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925018822/form4-07022025_120710.xml","form_type":"4"}},{"id":1097865,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T00:32:14.000Z","date":"2025-06-30","kind":"sale","planned":false,"acquired":false,"shares":18578,"price":6.8127,"value":126566.3406,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":3201709,"source":{"system":"sec-edgar","filing":"0001415889-25-018822","document":"form4-07022025_120710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925018822/form4-07022025_120710.xml","form_type":"4"}},{"id":1097864,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T00:32:14.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":19265,"price":6.91,"value":133121.15,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1113092,"source":{"system":"sec-edgar","filing":"0001415889-25-018822","document":"form4-07022025_120710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925018822/form4-07022025_120710.xml","form_type":"4"}},{"id":1097863,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T00:32:14.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":55735,"price":6.91,"value":385128.85,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":3220287,"source":{"system":"sec-edgar","filing":"0001415889-25-018822","document":"form4-07022025_120710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000141588925018822/form4-07022025_120710.xml","form_type":"4"}},{"id":1407809,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T22:54:09.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":79,"price":6.06,"value":478.74,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.05 to $6.11 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":66277,"source":{"system":"sec-edgar","filing":"0001415889-24-023399","document":"form4-09132024_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588924023399/form4-09132024_100903.xml","form_type":"4"}},{"id":1407808,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T22:54:09.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":6.06,"value":12120.0,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.05 to $6.11 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1679685,"source":{"system":"sec-edgar","filing":"0001415889-24-023399","document":"form4-09132024_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588924023399/form4-09132024_100903.xml","form_type":"4"}},{"id":1407807,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T22:54:09.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":11758,"price":6.06,"value":71253.48,"ownership":{"direct":false,"nature":"By 5AM Ventures VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.05 to $6.11 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are directly held by 5AM Ventures VII, L.P. (\"Ventures VII\"). 5AM Partners VII, LLC (\"Partners VII\") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":8167206,"source":{"system":"sec-edgar","filing":"0001415889-24-023399","document":"form4-09132024_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588924023399/form4-09132024_100903.xml","form_type":"4"}},{"id":1407806,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T22:54:09.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":1440,"price":6.6,"value":9504.0,"ownership":{"direct":false,"nature":"By 5AM Co-Investors II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by 5AM Co-Investors II, L.P. (\"Co-Investors II\"). Partners II is the sole general partner of Co-Investors II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Co-Investors II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":66356,"source":{"system":"sec-edgar","filing":"0001415889-24-023399","document":"form4-09132024_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588924023399/form4-09132024_100903.xml","form_type":"4"}},{"id":1407805,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T22:54:09.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":36504,"price":6.6,"value":240926.4,"ownership":{"direct":false,"nature":"By 5AM Ventures II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by 5AM Ventures II, L.P. (\"Ventures II\"). 5AM Partners II, LLC (\"Partners II\") is the sole general partner of Ventures II. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners II and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures II. Each of Partners II, Dr. Diekman and Dr. Rocklage disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1681685,"source":{"system":"sec-edgar","filing":"0001415889-24-023399","document":"form4-09132024_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588924023399/form4-09132024_100903.xml","form_type":"4"}},{"id":1407804,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T22:54:09.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":214556,"price":6.6,"value":1416069.6,"ownership":{"direct":false,"nature":"By 5AM Ventures VII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are directly held by 5AM Ventures VII, L.P. (\"Ventures VII\"). 5AM Partners VII, LLC (\"Partners VII\") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":8178964,"source":{"system":"sec-edgar","filing":"0001415889-24-023399","document":"form4-09132024_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588924023399/form4-09132024_100903.xml","form_type":"4"}},{"id":1574964,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-15T20:15:21.000Z","date":"2024-03-13","kind":"purchase","planned":false,"acquired":true,"shares":450000,"price":10,"value":4500000.0,"ownership":{"direct":false,"nature":"By 5AM Ventures VII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are directly held by 5AM Ventures VII, L.P. (\"Ventures VII\"). 5AM Partners VII, LLC (\"Partners VII\") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":8393520,"source":{"system":"sec-edgar","filing":"0001415889-24-008107","document":"form4-03152024_040305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000141588924008107/form4-03152024_040305.xml","form_type":"4"}},{"id":1662130,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":21270,"kind":"organization","name":"5AM Partners VII, LLC","position":1,"cik":"0001873545","reported_name":"5AM Partners VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21271,"kind":"organization","name":"5AM Ventures VII, L.P.","position":2,"cik":"0001844435","reported_name":"5AM Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21272,"kind":"organization","name":"5AM Partners II, LLC","position":3,"cik":"0001555952","reported_name":"5AM Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21273,"kind":"organization","name":"5AM Ventures II LP","position":4,"cik":"0001386509","reported_name":"5AM Ventures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21274,"kind":"organization","name":"5AM CO-INVESTORS II LP","position":5,"cik":"0001390376","reported_name":"5AM CO-INVESTORS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21276,"kind":"person","name":"PARMAR KUSH","position":7,"cik":"0001664281","reported_name":"PARMAR KUSH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":8,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T21:32:53.000Z","date":"2024-01-31","kind":"purchase","planned":false,"acquired":true,"shares":5206074,"price":2.31,"value":12026030.94,"ownership":{"direct":false,"nature":"By 5AM Ventures VII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are directly held by 5AM Ventures VII, L.P. (\"Ventures VII\"). 5AM Partners VII, LLC (\"Partners VII\") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports."}],"balance_after":7943520,"source":{"system":"sec-edgar","filing":"0001209191-24-002643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873545/000120919124002643/doc4.xml","form_type":"4"}},{"id":1920848,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-12T20:51:37.000Z","date":"2023-04-10","kind":"sale","planned":false,"acquired":false,"shares":3172769,"price":0.12,"value":380732.28,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.11 to $0.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001209191-23-024105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919123024105/doc4.xml","form_type":"4"}},{"id":1920847,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-12T20:51:37.000Z","date":"2023-04-10","kind":"sale","planned":false,"acquired":false,"shares":534855,"price":0.12,"value":64182.6,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.11 to $0.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-024105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919123024105/doc4.xml","form_type":"4"}},{"id":1920846,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-12T20:51:37.000Z","date":"2023-04-10","kind":"sale","planned":false,"acquired":false,"shares":12836489,"price":0.12,"value":1540378.68,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.11 to $0.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-024105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919123024105/doc4.xml","form_type":"4"}},{"id":1961138,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":1,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":2,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":3,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":4,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T21:35:35.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":100000,"price":8.2,"value":820000.0,"ownership":{"direct":false,"nature":"By 5AM Ventures V, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by 5AM Ventures V, L.P. (\"Ventures V\"). 5AM Partners V, LLC is the general partner of Ventures V and may be deemed to have sole investment and voting power over the shares held by Ventures V. Each of Andrew Schwab, Dr. Kush Parmar and Dr. Scott Rocklage is a Managing Member of 5AM Partners V, LLC, and may be deemed to have shared voting and dispositive power over the shares held by Ventures V. Therefore, each of Andrew  Schwab, Dr. Kush Parmar, Dr. Scott Rocklage, and 5AM Partners V, LLC may be deemed to beneficially own the shares held by Ventures V, and each disclaims beneficial ownership over the shares held by Ventures V except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports."}],"balance_after":2378969,"source":{"system":"sec-edgar","filing":"0001209191-23-017533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000120919123017533/doc4.xml","form_type":"4"}},{"id":2098371,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T15:38:15.000Z","date":"2022-11-30","kind":"other","acquired":false,"shares":982453,"ownership":{"direct":false,"nature":"5AM Opportunities I, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Eli Lilly and Company (\"Parent\") and Kearny Acquisition Corporation (\"Merger Sub\"), dated as of October 17, 2022, these shares of common stock, par value $0.0001 per share, of the Issuer (\"Shares\") were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for..."},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont. from footnote 1)...(i) $12.50 per Share, net to the stockholder in cash, without interest (the \"Cash Consideration\") and less any applicable tax withholding, plus (ii) one non-tradable contingent value right (\"CVR\")  per Share, which represents the contractual right to receive contingent payments of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of certain specified milestones in accordance with the terms and subject to the conditions of a Contingent Value Rights Agreement, dated as of November 30, 2022, by and among Parent, Merger Sub, Computershare Inc. and Computershare Trust Company, N.A."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Eli Lilly and Company (\"Parent\") and Kearny Acquisition Corporation (\"Merger Sub\"), dated as of October 17, 2022, these shares of common stock, par value $0.0001 per share, of the Issuer (\"Shares\") were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for..."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the general partner of 5AM Opportunities I, L.P. (\"Opportunities I\") and may be deemed to have sole investment and voting power over the shares held by Opportunities I. Each of Andrew Schwab and Dr. Kush Parmar is a Managing Member of Opportunities GP, and may be deemed to have shared voting and dispositive power over the shares held by Opportunities I. Therefore, each of Mr. Schwab, Dr. Parmar and Opportunities GP may be deemed to beneficially own the shares held by Opportunities I.  Each of Mr. Schwab and Opportunities GP disclaims beneficial ownership over the shares held by Opportunities I except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by Opportunities I."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-059372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919122059372/doc4.xml","form_type":"4"}},{"id":2098370,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T15:38:15.000Z","date":"2022-11-30","kind":"other","acquired":false,"shares":3153333,"ownership":{"direct":false,"nature":"By 5AM Ventures V, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Eli Lilly and Company (\"Parent\") and Kearny Acquisition Corporation (\"Merger Sub\"), dated as of October 17, 2022, these shares of common stock, par value $0.0001 per share, of the Issuer (\"Shares\") were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for..."},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont. from footnote 1)...(i) $12.50 per Share, net to the stockholder in cash, without interest (the \"Cash Consideration\") and less any applicable tax withholding, plus (ii) one non-tradable contingent value right (\"CVR\")  per Share, which represents the contractual right to receive contingent payments of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of certain specified milestones in accordance with the terms and subject to the conditions of a Contingent Value Rights Agreement, dated as of November 30, 2022, by and among Parent, Merger Sub, Computershare Inc. and Computershare Trust Company, N.A."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Eli Lilly and Company (\"Parent\") and Kearny Acquisition Corporation (\"Merger Sub\"), dated as of October 17, 2022, these shares of common stock, par value $0.0001 per share, of the Issuer (\"Shares\") were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for..."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by 5AM Ventures V, L.P. (\"Ventures V\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"5AM Partners V, LLC (\"Partners V\") is the general partner of Ventures V and may be deemed to have sole investment and voting power over the shares held by Ventures V. Each of Andrew Schwab, Dr. Kush Parmar and Dr. Scott Rocklage is a Managing Member of Partners V, and may be deemed to have shared voting and dispositive power over the shares held by Ventures V. Therefore, each of Mr. Schwab, Dr. Parmar, Dr. Rocklage, and Partners V may be deemed to beneficially own the shares held by Ventures V. Each of Mr. Schwab, Dr. Rocklage, and Partners V disclaims beneficial ownership over the shares held by Ventures V except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-059372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919122059372/doc4.xml","form_type":"4"}},{"id":2115961,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-16T01:32:51.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":2551,"price":2.52,"value":6428.52,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.655 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":534855,"source":{"system":"sec-edgar","filing":"0001209191-22-057195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122057195/doc4.xml","form_type":"4"}},{"id":2115960,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-16T01:32:51.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":61222,"price":2.52,"value":154279.44,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.655 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":12836489,"source":{"system":"sec-edgar","filing":"0001209191-22-057195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122057195/doc4.xml","form_type":"4"}},{"id":2115959,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-16T01:32:51.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":485,"price":2.79,"value":1353.15,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":537406,"source":{"system":"sec-edgar","filing":"0001209191-22-057195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122057195/doc4.xml","form_type":"4"}},{"id":2115958,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-16T01:32:51.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":11643,"price":2.79,"value":32483.97,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":12897711,"source":{"system":"sec-edgar","filing":"0001209191-22-057195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122057195/doc4.xml","form_type":"4"}},{"id":2115957,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-16T01:32:51.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":1175,"price":3.19,"value":3748.25,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.33 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":537891,"source":{"system":"sec-edgar","filing":"0001209191-22-057195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122057195/doc4.xml","form_type":"4"}},{"id":2115956,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-16T01:32:51.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":28205,"price":3.19,"value":89973.95,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.33 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":12909354,"source":{"system":"sec-edgar","filing":"0001209191-22-057195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122057195/doc4.xml","form_type":"4"}},{"id":2126981,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-02T23:49:40.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":423,"price":2.72,"value":1150.56,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":539066,"source":{"system":"sec-edgar","filing":"0001209191-22-055425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122055425/doc4.xml","form_type":"4"}},{"id":2126980,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-02T23:49:40.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":10155,"price":2.72,"value":27621.6,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12937559,"source":{"system":"sec-edgar","filing":"0001209191-22-055425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122055425/doc4.xml","form_type":"4"}},{"id":2126979,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-02T23:49:40.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":59,"price":2.8,"value":165.2,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":539489,"source":{"system":"sec-edgar","filing":"0001209191-22-055425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122055425/doc4.xml","form_type":"4"}},{"id":2126978,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-02T23:49:40.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":1408,"price":2.8,"value":3942.4,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":12947714,"source":{"system":"sec-edgar","filing":"0001209191-22-055425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122055425/doc4.xml","form_type":"4"}},{"id":2126977,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-02T23:49:40.000Z","date":"2022-10-31","kind":"sale","acquired":false,"shares":1687,"price":2.78,"value":4689.86,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":539548,"source":{"system":"sec-edgar","filing":"0001209191-22-055425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122055425/doc4.xml","form_type":"4"}},{"id":2126976,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-02T23:49:40.000Z","date":"2022-10-31","kind":"sale","acquired":false,"shares":40477,"price":2.78,"value":112526.06,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":12949122,"source":{"system":"sec-edgar","filing":"0001209191-22-055425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122055425/doc4.xml","form_type":"4"}},{"id":2139178,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T19:10:31.000Z","date":"2022-10-10","kind":"sale","acquired":false,"shares":87036,"price":4.09,"value":355977.24,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein."}],"balance_after":410268,"source":{"system":"sec-edgar","filing":"0001209191-22-053401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122053401/doc4.xml","form_type":"4"}},{"id":2139177,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T19:10:31.000Z","date":"2022-10-10","kind":"sale","acquired":false,"shares":19017,"price":4.09,"value":77779.53,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":92983,"source":{"system":"sec-edgar","filing":"0001209191-22-053401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122053401/doc4.xml","form_type":"4"}},{"id":2139176,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T19:10:31.000Z","date":"2022-10-10","kind":"sale","acquired":false,"shares":456413,"price":4.09,"value":1866729.17,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":2231601,"source":{"system":"sec-edgar","filing":"0001209191-22-053401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122053401/doc4.xml","form_type":"4"}},{"id":2139175,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T19:10:31.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":5808,"price":5.02,"value":29156.16,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein."}],"balance_after":497304,"source":{"system":"sec-edgar","filing":"0001209191-22-053401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122053401/doc4.xml","form_type":"4"}},{"id":2139174,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T19:10:31.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":1269,"price":5.02,"value":6370.38,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":112000,"source":{"system":"sec-edgar","filing":"0001209191-22-053401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122053401/doc4.xml","form_type":"4"}},{"id":2139173,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T19:10:31.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":30457,"price":5.02,"value":152894.14,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":2688014,"source":{"system":"sec-edgar","filing":"0001209191-22-053401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122053401/doc4.xml","form_type":"4"}},{"id":2157179,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:03:25.000Z","date":"2022-09-16","kind":"sale","acquired":false,"shares":14,"price":1.75,"value":24.5,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"balance_after":541235,"source":{"system":"sec-edgar","filing":"0001209191-22-050387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122050387/doc4.xml","form_type":"4"}},{"id":2157178,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:03:25.000Z","date":"2022-09-16","kind":"sale","acquired":false,"shares":337,"price":1.75,"value":589.75,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"balance_after":12989599,"source":{"system":"sec-edgar","filing":"0001209191-22-050387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122050387/doc4.xml","form_type":"4"}},{"id":2157177,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:03:25.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":10910,"price":1.81,"value":19747.1,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.92 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":541249,"source":{"system":"sec-edgar","filing":"0001209191-22-050387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122050387/doc4.xml","form_type":"4"}},{"id":2157176,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:03:25.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":261840,"price":1.81,"value":473930.4,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.92 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":12989936,"source":{"system":"sec-edgar","filing":"0001209191-22-050387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122050387/doc4.xml","form_type":"4"}},{"id":2157175,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:03:25.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":11403,"price":1.94,"value":22121.82,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.07 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":552159,"source":{"system":"sec-edgar","filing":"0001209191-22-050387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122050387/doc4.xml","form_type":"4"}},{"id":2157174,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-16T22:03:25.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":273664,"price":1.94,"value":530908.16,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.07 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":13251776,"source":{"system":"sec-edgar","filing":"0001209191-22-050387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122050387/doc4.xml","form_type":"4"}},{"id":2162992,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-09T00:01:29.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":12173,"price":1.81,"value":22033.13,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"balance_after":563562,"source":{"system":"sec-edgar","filing":"0001209191-22-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122049237/doc4.xml","form_type":"4"}},{"id":2162991,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-09T00:01:29.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":292149,"price":1.81,"value":528789.69,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"balance_after":13525440,"source":{"system":"sec-edgar","filing":"0001209191-22-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122049237/doc4.xml","form_type":"4"}},{"id":2162990,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-09T00:01:29.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":6181,"price":1.92,"value":11867.52,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":575735,"source":{"system":"sec-edgar","filing":"0001209191-22-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122049237/doc4.xml","form_type":"4"}},{"id":2162989,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-09T00:01:29.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":148337,"price":1.92,"value":284807.04,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":13817589,"source":{"system":"sec-edgar","filing":"0001209191-22-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122049237/doc4.xml","form_type":"4"}},{"id":2162988,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-09T00:01:29.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":12446,"price":2.36,"value":29372.56,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":581916,"source":{"system":"sec-edgar","filing":"0001209191-22-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122049237/doc4.xml","form_type":"4"}},{"id":2162987,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-09T00:01:29.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":298714,"price":2.36,"value":704965.04,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":13965926,"source":{"system":"sec-edgar","filing":"0001209191-22-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122049237/doc4.xml","form_type":"4"}},{"id":2163141,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T19:58:06.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":30173,"price":4.75,"value":143321.75,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein."}],"balance_after":503112,"source":{"system":"sec-edgar","filing":"0001209191-22-049235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122049235/doc4.xml","form_type":"4"}},{"id":2163140,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T19:58:06.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":6793,"price":4.75,"value":32266.75,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":113269,"source":{"system":"sec-edgar","filing":"0001209191-22-049235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122049235/doc4.xml","form_type":"4"}},{"id":2163139,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T19:58:06.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":163034,"price":4.75,"value":774411.5,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":2718471,"source":{"system":"sec-edgar","filing":"0001209191-22-049235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122049235/doc4.xml","form_type":"4"}},{"id":2163138,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T19:58:06.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":4016,"price":5.52,"value":22168.32,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein."}],"balance_after":533285,"source":{"system":"sec-edgar","filing":"0001209191-22-049235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122049235/doc4.xml","form_type":"4"}},{"id":2163137,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T19:58:06.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":904,"price":5.52,"value":4990.08,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":120062,"source":{"system":"sec-edgar","filing":"0001209191-22-049235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122049235/doc4.xml","form_type":"4"}},{"id":2163136,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T19:58:06.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":21702,"price":5.52,"value":119795.04,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":2881505,"source":{"system":"sec-edgar","filing":"0001209191-22-049235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122049235/doc4.xml","form_type":"4"}},{"id":2179317,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-19T00:05:45.000Z","date":"2022-08-18","kind":"sale","acquired":false,"shares":8910,"price":1.55,"value":13810.5,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"balance_after":594362,"source":{"system":"sec-edgar","filing":"0001209191-22-046773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122046773/doc4.xml","form_type":"4"}},{"id":2179316,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-19T00:05:45.000Z","date":"2022-08-18","kind":"sale","acquired":false,"shares":213851,"price":1.55,"value":331469.05,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"balance_after":14264640,"source":{"system":"sec-edgar","filing":"0001209191-22-046773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122046773/doc4.xml","form_type":"4"}},{"id":2179315,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-19T00:05:45.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":403,"price":1.71,"value":689.13,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":603272,"source":{"system":"sec-edgar","filing":"0001209191-22-046773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122046773/doc4.xml","form_type":"4"}},{"id":2179314,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-19T00:05:45.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":9674,"price":1.71,"value":16542.54,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":14478491,"source":{"system":"sec-edgar","filing":"0001209191-22-046773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122046773/doc4.xml","form_type":"4"}},{"id":2179313,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-19T00:05:45.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":6686,"price":1.78,"value":11901.08,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":603675,"source":{"system":"sec-edgar","filing":"0001209191-22-046773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122046773/doc4.xml","form_type":"4"}},{"id":2179312,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":2,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":3,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":5,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-19T00:05:45.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":160476,"price":1.78,"value":285647.28,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":14488165,"source":{"system":"sec-edgar","filing":"0001209191-22-046773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240357/000120919122046773/doc4.xml","form_type":"4"}},{"id":2240287,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":1,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":2,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":4,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":5,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":6,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T21:02:08.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":99671,"price":12.5,"value":1245887.5,"ownership":{"direct":false,"nature":"By 5AM Ventures V, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"Ventures V\"). 5AM Partners V, LLC is the general partner of Ventures V and may be deemed to have sole investment and voting power over the shares held by Ventures V. Each of Andrew Schwab, Dr. Kush Parmar and Dr. Scott Rocklage is a Managing Member of 5AM Partners V, LLC, and may be deemed to have shared voting and dispositive power over the shares held by Ventures V. Therefore, each of Andrew  Schwab, Dr. Kush Parmar, Dr. Scott Rocklage, and 5AM Partners V, LLC may be deemed to beneficially own the shares held by Ventures V, and each disclaims beneficial ownership over the shares held by Ventures V except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports."}],"balance_after":2478969,"source":{"system":"sec-edgar","filing":"0001209191-22-034858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000120919122034858/doc4.xml","form_type":"4"}},{"id":2240286,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":1,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":2,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":4,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":5,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":6,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T21:02:08.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":50329,"price":12.5,"value":629112.5,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities I\"). 5AM Opportunities I (GP), LLC is the general partner of Opportunities I and may be deemed to have sole investment and voting power over the shares held  by Opportunities I. Each of Andrew Schwab and Dr. Kush Parmar is a Managing Member of 5AM Opportunities I (GP), LLC, and may be deemed to have shared voting and dispositive power over the shares held by Opportunities I. Therefore, each of Andrew Schwab, Dr. Kush Parmar and 5AM Opportunities I(GP),  LLC may be deemed to beneficially own the shares held by Opportunities I, and each disclaims beneficial ownership over the shares held by Opportunities I except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports."}],"balance_after":1251755,"source":{"system":"sec-edgar","filing":"0001209191-22-034858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000120919122034858/doc4.xml","form_type":"4"}},{"id":2256844,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":1,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":2,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":4,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":5,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":6,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T22:31:58.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":66447,"price":13,"value":863811.0,"ownership":{"direct":false,"nature":"By 5AM Ventures V, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"Ventures V\"). 5AM Partners V, LLC is the general partner of Ventures V and may be deemed to have sole investment and voting power over the shares held by Ventures V. Each of Andrew Schwab, Dr. Kush Parmar and Dr. Scott Rocklage is a Managing Member of 5AM Partners V, LLC, and may be deemed to have shared voting and dispositive power over the shares held by Ventures V. Therefore, each of Andrew  Schwab, Dr. Kush Parmar, Dr. Scott Rocklage, and 5AM Partners V, LLC may be deemed to beneficially own the shares held by Ventures V, and each disclaims beneficial ownership over the shares held by Ventures V except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports."}],"balance_after":2578640,"source":{"system":"sec-edgar","filing":"0001209191-22-031966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000120919122031966/doc4.xml","form_type":"4"}},{"id":2256843,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":1,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":2,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":4,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":5,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":6,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T22:31:58.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":33553,"price":13,"value":436189.0,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities I\"). 5AM Opportunities I (GP), LLC is the general partner of Opportunities I and may be deemed to have sole investment and voting power over the shares held  by Opportunities I. Each of Andrew Schwab and Dr. Kush Parmar is a Managing Member of 5AM Opportunities I (GP), LLC, and may be deemed to have shared voting and dispositive power over the shares held by Opportunities I. Therefore, each of Andrew Schwab, Dr. Kush Parmar and 5AM Opportunities I(GP),  LLC may be deemed to beneficially own the shares held by Opportunities I, and each disclaims beneficial ownership over the shares held by Opportunities I except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports."}],"balance_after":1302084,"source":{"system":"sec-edgar","filing":"0001209191-22-031966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000120919122031966/doc4.xml","form_type":"4"}},{"id":2297754,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-13T16:51:24.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":40733,"price":5,"value":203665.0,"ownership":{"direct":false,"nature":"By 5AM Opportunities I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein."}],"balance_after":537301,"source":{"system":"sec-edgar","filing":"0001209191-22-024292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122024292/doc4.xml","form_type":"4"}},{"id":2297753,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-13T16:51:24.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":9171,"price":5,"value":45855.0,"ownership":{"direct":false,"nature":"By 5AM Co-Investors IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by 5AM Co-Investors IV, L.P. (\"Co-Investors IV\"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":120966,"source":{"system":"sec-edgar","filing":"0001209191-22-024292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122024292/doc4.xml","form_type":"4"}},{"id":2297752,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":114513,"kind":"organization","name":"5AM Partners IV, LLC","position":1,"cik":"0001589314","reported_name":"5AM Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114515,"kind":"organization","name":"5AM Co-Investors IV, L.P.","position":2,"cik":"0001593361","reported_name":"5AM Co-Investors IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":4,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114514,"kind":"organization","name":"5AM Ventures IV, L.P.","position":5,"cik":"0001589315","reported_name":"5AM Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21275,"kind":"person","name":"DIEKMAN JOHN D","position":6,"cik":"0001240357","reported_name":"DIEKMAN JOHN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":7,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":8,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-13T16:51:24.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":220096,"price":5,"value":1100480.0,"ownership":{"direct":false,"nature":"By 5AM Ventures IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by 5AM Ventures IV, L.P. (\"Ventures IV\"). 5AM Partners IV, LLC (\"Partners IV\") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman,  Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":2903207,"source":{"system":"sec-edgar","filing":"0001209191-22-024292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000120919122024292/doc4.xml","form_type":"4"}},{"id":2404544,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":1,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":2,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":4,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":5,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":6,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-10T23:24:23.000Z","date":"2022-02-08","kind":"sale","acquired":false,"shares":139539,"price":13.05,"value":1820983.95,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"Ventures V\"). 5AM Partners V, LLC is the general partner of Ventures V and may be deemed to have sole investment and voting power over the shares held by Ventures V. Each of Andrew Schwab, Dr. Kush Parmar and Dr. Scott Rocklage is a Managing Member of 5AM Partners V, LLC, and may be deemed to have shared voting and dispositive power over the shares held by Ventures V. Therefore, each of Andrew  Schwab, Dr. Kush Parmar, Dr. Scott Rocklage, and 5AM Partners V, LLC may be deemed to beneficially own the shares held by Ventures V, and each disclaims beneficial ownership over the shares held by Ventures V except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports."}],"balance_after":2645087,"source":{"system":"sec-edgar","filing":"0001209191-22-008584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000120919122008584/doc4.xml","form_type":"4"}},{"id":2404543,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":1,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":2,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":3,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":4,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":5,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":6,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-10T23:24:23.000Z","date":"2022-02-08","kind":"sale","acquired":false,"shares":70461,"price":13.05,"value":919516.05,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities I\"). 5AM Opportunities I (GP), LLC is the general partner of Opportunities I and may be deemed to have sole investment and voting power over the shares held  by Opportunities I. Each of Andrew Schwab and Dr. Kush Parmar is a Managing Member of 5AM Opportunities I (GP), LLC, and may be deemed to have shared voting and dispositive power over the shares held by Opportunities I. Therefore, each of Andrew Schwab, Dr. Kush Parmar and 5AM Opportunities I(GP),  LLC may be deemed to beneficially own the shares held by Opportunities I, and each disclaims beneficial ownership over the shares held by Opportunities I except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports."}],"balance_after":1335637,"source":{"system":"sec-edgar","filing":"0001209191-22-008584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000120919122008584/doc4.xml","form_type":"4"}},{"id":2524570,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-11-05T01:10:54.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":2302026,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":318140},"source":{"system":"sec-edgar","filing":"0001209191-21-063040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000120919121063040/doc4.xml","form_type":"4"}},{"id":2524569,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-11-05T01:10:54.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":1841620,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by 5AM Ventures V, L.P. (\"5AM V\"). 5AM Partners V, LLC (\"5AM Partners\") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":254512},"source":{"system":"sec-edgar","filing":"0001209191-21-063040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000120919121063040/doc4.xml","form_type":"4"}},{"id":2524568,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":25023,"kind":"organization","name":"5AM Ventures V, L.P.","position":1,"cik":"0001674324","reported_name":"5AM Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25024,"kind":"organization","name":"5AM Partners V, LLC","position":2,"cik":"0001791889","reported_name":"5AM Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25025,"kind":"organization","name":"5AM Opportunities I, L.P.","position":3,"cik":"0001753000","reported_name":"5AM Opportunities I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25026,"kind":"organization","name":"5AM Opportunities I (GP), LLC","position":4,"cik":"0001790778","reported_name":"5AM Opportunities I (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21277,"kind":"person","name":"ROCKLAGE SCOTT M","position":5,"cik":"0001219014","reported_name":"ROCKLAGE SCOTT M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18314,"kind":"person","name":"Schwab Andrew J.","position":6,"cik":"0001598549","reported_name":"Schwab Andrew J.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-11-05T01:10:54.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":4082613,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series Seed Preferred Stock, Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.1382 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by 5AM Opportunities I, L.P. (\"Opportunities\"). 5AM Opportunities I (GP), LLC (\"Opportunities GP\") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":564217},"source":{"system":"sec-edgar","filing":"0001209191-21-063040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000120919121063040/doc4.xml","form_type":"4"}}],"next_cursor":"2021-11-05T01:10:54.000000Z,2524568"}